Top

Cancer Immunology, Immunotherapy

Published in:

01-06-2008 | Erratum

Dendritic cell vaccination and other strategies to tip the balance of the immune system

DC2007 5th international meeting, July 16–18, Bamberg, Germany

Authors: Niels Schaft, Katrin Birkholz, Christian Hofmann, Martina Schmid, Gabi Theiner, Jan Dörrie

Published in: Cancer Immunology, Immunotherapy | Issue 6/2008

Excerpt

Due to an oversight, two summaries of presentations held at this meeting were not integrated into the text. We apologize to the speakers for this mistake. The summary of the presentation of Pierre Coulie should have been in the section “Cancer vaccination in general”, and the summary of the presentation of Ugur Sahin should have been in “RNA electroporation”. These are presented here: …

Lonchay C, Van Der Bruggen P, Connerotte T, Hanagiri T, Coulie P, Colau D, Lucas S, Van Pel A, Thielemans K, van Baren N, Boon T (2004) Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen. Proc Natl Acad Sci USA 101(Suppl 2):14631–14638PubMedCrossRef

Germeau C, Ma W, Schiavetti F, Lurquin C, Henry E, Vigneron N, Brasseur F, Lethe B, De Plaen E, Velu T, Boon T, Coulie PG (2005) High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens. J Exp Med 201:241–248PubMedCrossRef

Holtkamp S, Kreiter S, Selmi A, Simon P, Koslowski M, Huber C, Tureci O, Sahin U (2006) Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 108:4009–4017PubMedCrossRef

Lizee G, Basha G, Tiong J, Julien JP, Tian M, Biron KE, Jefferies WA (2003) Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat Immunol 4:1065–1073PubMedCrossRef

Kreiter S, Konrad T, Sester M, Huber C, Türeci Ö, Sahin U (2007) Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA. Cancer Immunol Immunother 56:1577–87PubMedCrossRef

Kreiter S, Selmi A, Diken M, Sebastian M, Osterloh P, Schild H, Huber C, Türeci Ö, Sahin U (2008) Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals. J Immunol 180:309–318PubMed

Title: Dendritic cell vaccination and other strategies to tip the balance of the immune system
DC2007 5th international meeting, July 16–18, Bamberg, Germany
Authors: Niels Schaft
Katrin Birkholz
Christian Hofmann
Martina Schmid
Gabi Theiner
Jan Dörrie
Publication date: 01-06-2008
Publisher: Springer-Verlag
Published in: Cancer Immunology, Immunotherapy / Issue 6/2008
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s00262-008-0488-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2008

CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells

Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner

Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells

Rapid accumulation of adoptively transferred CD8+ T cells at the tumor site is associated with long-term control of SV40 T antigen-induced tumors

Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation

Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation

Keynote webinar | Spotlight on antibody–drug conjugates in cancer